Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) shares crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $55.35 and traded as low as $54.95. Lonza Group shares last traded at $55.15, with a volume of 48,975 shares traded.
Wall Street Analyst Weigh In
Separately, Deutsche Bank Aktiengesellschaft upgraded Lonza Group from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd.
Read Our Latest Stock Report on LZAGY
Lonza Group Price Performance
Lonza Group Company Profile
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.
Featured Stories
- Five stocks we like better than Lonza Group
- What is the FTSE 100 index?
- Comprehensive Analysis of PayPal Stock
- What is a Bond Market Holiday? How to Invest and Trade
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- Investing In Automotive Stocks
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.